X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs SANOFI INDIA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD SANOFI INDIA STRIDES SHASUN LTD/
SANOFI INDIA
 
P/E (TTM) x 13.2 33.6 39.2% View Chart
P/BV x 1.5 6.4 23.9% View Chart
Dividend Yield % 0.6 1.4 46.0%  

Financials

 STRIDES SHASUN LTD   SANOFI INDIA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
SANOFI INDIA
Dec-16
STRIDES SHASUN LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,2754,560 28.0%   
Low Rs9184,400 20.9%   
Sales per share (Unadj.) Rs389.61,028.5 37.9%  
Earnings per share (Unadj.) Rs28.0129.0 21.7%  
Cash flow per share (Unadj.) Rs48.9186.0 26.3%  
Dividends per share (Unadj.) Rs4.5068.00 6.6%  
Dividend yield (eoy) %0.41.5 27.0%  
Book value per share (Unadj.) Rs303.1753.6 40.2%  
Shares outstanding (eoy) m89.4223.03 388.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.84.4 64.6%   
Avg P/E ratio x39.234.7 112.8%  
P/CF ratio (eoy) x22.424.1 93.1%  
Price / Book Value ratio x3.65.9 60.8%  
Dividend payout %16.152.7 30.5%   
Avg Mkt Cap Rs m98,036103,174 95.0%   
No. of employees `0005.83.6 160.1%   
Total wages/salary Rs m5,8813,592 163.7%   
Avg. sales/employee Rs Th6,005.96,537.7 91.9%   
Avg. wages/employee Rs Th1,014.0991.4 102.3%   
Avg. net profit/employee Rs Th431.2819.8 52.6%   
INCOME DATA
Net Sales Rs m34,83423,686 147.1%  
Other income Rs m1,686708 238.1%   
Total revenues Rs m36,52024,394 149.7%   
Gross profit Rs m6,4285,281 121.7%  
Depreciation Rs m1,8721,313 142.5%   
Interest Rs m2,26915 15,128.7%   
Profit before tax Rs m3,9734,661 85.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4701,691 27.8%   
Profit after tax Rs m2,5012,970 84.2%  
Gross profit margin %18.522.3 82.8%  
Effective tax rate %11.836.3 32.6%   
Net profit margin %7.212.5 57.3%  
BALANCE SHEET DATA
Current assets Rs m38,16515,673 243.5%   
Current liabilities Rs m30,4026,678 455.3%   
Net working cap to sales %22.338.0 58.7%  
Current ratio x1.32.3 53.5%  
Inventory Days Days7776 101.8%  
Debtors Days Days10422 468.2%  
Net fixed assets Rs m37,6398,098 464.8%   
Share capital Rs m894230 388.3%   
"Free" reserves Rs m26,21017,088 153.4%   
Net worth Rs m27,10517,356 156.2%   
Long term debt Rs m16,3770-   
Total assets Rs m81,16825,400 319.6%  
Interest coverage x2.8311.7 0.9%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.9 46.0%   
Return on assets %5.911.8 50.0%  
Return on equity %9.217.1 53.9%  
Return on capital %12.126.9 44.7%  
Exports to sales %024.5 0.0%   
Imports to sales %028.0 0.0%   
Exports (fob) Rs mNA5,801 0.0%   
Imports (cif) Rs mNA6,627 0.0%   
Fx inflow Rs m13,4657,145 188.5%   
Fx outflow Rs m4,0766,846 59.5%   
Net fx Rs m9,389299 3,140.3%   
CASH FLOW
From Operations Rs m2,8813,226 89.3%  
From Investments Rs m-7,051-1,555 453.5%  
From Financial Activity Rs m3,382-1,818 -186.0%  
Net Cashflow Rs m-788-147 535.8%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 37.8 14.4 262.5%  
FIIs % 8.6 14.6 58.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 10.5 246.7%  
Shareholders   56,241 15,184 370.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   DR. REDDYS LAB  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 22, 2018 02:31 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - ALEMBIC LTD COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS